of Medicine and Dentistry, Rochester, New York 14642 Atrial natriuretic peptide (ANP) exerts hemodynamic effects by direct venodilation in the chick embryo. We hypothesized that ANP-induced venodilation affects ventricular diastolic filling resulting in reduced ventricular preload. Chick ANP (0.1 p g in 10 p L of normal saline) was suffused onto the vitelline vascular bed in stage 21 (3% d) chick embryos. Equivalent aliquots of normal saline were suffused as sham controls, and normal embryos received no suffusion. We measured simultancously dorsal aortic blood velocity and atrioventricular blood velocity with a 20-MHz pulsed-Doppler velocity meter. Analog wave forms were digitally sampled at 500 Hz, and the dorsal aortic crosssectional area was used to calculate dorsal aortic blood flow. Passive ventricular filling volume equaled dorsal aortic stroke volume multiplied by the fraction of passive area; active filling volume equaled dorsal aortic stroke volume multiplied by the fraction of active area. Data were summarized as mean 2 SEM (n 2 7 per group) and analyzed by analysis of variance. Cycle ANP is one member of a family of vasoactive hormones with conserved sequences across species, and at least three protein subclasses and three receptors have been identified (1). In contrast to its localized synthesis in the atrial appendages of the healthy mature heart, during primary cardiac morphogenesis, "atrial" natriuretic peptide is widely distributed in the embryonic myocardium (2,3). Of note, the resynthesis of ANP is a useful marker for myocyte hypertrophy (4). In the embryonic circulation, ANP exerts its hemodynamic effect by direct vasodilation, decreasing venous and arterial pressures (5). The microvascular mechanism of the ANP response may be through vascular permeability or by altered Starling forces across the capillary beds (6, 7). Because the early developing cardiovascular system is not innervated (8) and the kidneys are not yet developed (9), cardiovascular function is sensitive to mechanisms that alter hemodynamic load.
We use the technique of pulsed-Doppler measurement of blood velocity and flow to define embryonic diastolic function (10, 11). The combination of simultaneous AV and dorsal aortic blood flow profiles accurately defines passive and active ventricular filling volumes (10). Embryonic cardiovascular performance can be defined during normal growth and development and after interventions that alter cycle length or loading conditions (12, 13). Since the embryonic ventricle is relatively noncompliant, embryonic cardiovascular function is extremely sensitive to diastolic filling time and to loading conditions (12).
The embryonic ventricle responds to alterations in preload via a linear relationship between end-diastolic volume and stroke volume (12). In contrast to the mature circulation, the embryonic cardiovascular system lacks a heart rate response to compensate for reduced ventricular preload. We therefore hypothesized that ANP-induced venodilation would alter passive ventricular diastolic filling, resulting in reduced ventricular preload and subsequent reduced cardiac output. The sensitivity of the embryonic cardiovascular system to exogenous ANP further substantiates the role of constitutive ANP in the regulation of the preinnervated embryonic circulation.
METHODS
Fertile white Leghorn chicken eggs were incubated blunt end up in a forced-draft 38.5"C incubator to Hamburger-Hamilton stage 21 (3% d) (14). We measured simultaneously dorsal aortic blood flow and AV blood velocity with a 20-MHz pulsed-Doppler velocity meter using 0.5-mm piezoelectric crystals (10, 11). Analog wave forms were digitally sampled at 500 Hz with an analogldigital data acquisition system. Data were stored in a 5%-inch 150 Megabytes Bernoulli cartridge (Iomega, Roy, UT). After acquiring 1 min of baseline velocity, we suffused 0.1 p g of synthetic chicken ANP (Sigma Chemical Co., St. Louis, MO) in 10 p L of normal saline to the vitelline vascular bed and observed the data for 4 min. We selected the ANP dose previously reported to produce venodilation in the chick embryo (5). Sham embryos were suffused with equivalent aliquots of normal saline, and normal embryos received no suffusion. Thc ANP solution and the normal saline were warmed to embryo temperature with a water bath (37°C). We monitored embryo temperature with a 3.0-mm flat disc thermistor placed on the surface of the vitelline vascular bed adjacent to the embryo and maintained constant embryo temperature using a warming lamp.
Passive filling (P) was defined in the AV blood velocity profile from end-systole to the onset of the a-wave, and active filling (A) from the onset of the a-wave to the onset of systole (Fig. 1) . Cycle length was measured as the time between the consecutive dorsal aortic blood velocities. Dorsal aortic and both passive and active AV velocity profiles were integrated over time using a wave form analysis software (Datapac, RUN Technologies, Laguna Nigual, CA). Blood flow was calculated from the integral of dorsal aortic velocity and the aortic cross-sectional area. Passive ventricular filling volume equaled dorsal aortic stroke volume multiplied by the passive area fraction, and active ventricular filling volume equaled dorsal aortic stroke volume multiplied by the active area fraction (10).
Seven or more embryos were measured from ANP-suffused, sham, and normal embryos. For each embryo, we analyzed at least 15 consecutive cycles at the beginning of each minute. The data were summarized as mean + SEM and statistical compared one-way and two-way analysis of variance. Significance level was defined as a p valuc of less than 5% ( p < 0.05).
RESULTS
Cycle lengths were similar in ANP-suffused, sham control, and normal embryos throughout the time period (Fig. 2) . After 4 min, dorsal aortic blood flow decreased by 46.9% in ANPsuffused embryos ( p < 0.05), but was similar in sham control and normal embryos ( p > 0.05, Table 1 ). Dorsal aortic stroke volume reflected similar changes in the ANP-treated, sham control, and normal embryo groups (Fig. 3) .
Passive AV flow decreased from 0.28 2 0.01 mm3/s at baseline to 0.05 -t 0.02 mmys at 4 min postsuffusion in ANP-suffused embryos (p < 0.05) (Fig. 4) . Passive AV flows were similar to baseline values sham control and normal embryo groups after 4 min. Passive AV filling volumes reflected similar changes as in the passive AV flows of the ANP-treated, sham control, and normal embryo groups (Table 2) .
Active AV flows and filling volumes were similar among the ANP-suffused, sham control, and normal embryos (Fig. 4) . Passivelactive filling ratio decreased from 0.64 ? 0.07 at baseline to 0.32 t 0.08 at 4 min in ANP-suffused embryos ( p < 0.05) (Fig. 5) . Passivelactive filling ratio was unchanged in sham and normal embryos.
DISCUSSION
As has been noted in several studies of experimentally altered embryonic cardiovascular function, heart rate did not increase in response to decreased ventricular filling. In contrast, the mature cardiovascular system adjusts heart rate, myocardial contractility, and loading condition to main cardiac output. Before functional autonomic innervation, the embryonic myocardium lacks the ability to acutely alter heart rate in response to altered hemodynamic conditions (13). Likewise, early in primary cardiac morphogenesis the embryonic contractile response is limited by an underdeveloped calcium handling system and incomplete myofiber assembly (15). When considered from the opposite perspective, the lack of acute heart rate and contractility adaptive responses highlights the importance of ventricular preload and afterload in the regulation of embryonic cardiovascular performance. Our finding that ANP-mediated vasodilation reduces passive ventricular filling underscores the importance of venolatrial coupling and atrial conduit function in determining ventricular preload. The embryonic heart depends on diastolic filling time and both passive and active filling volumes to maintain adequate ventricular preload (10, 13). When cycle length is altered by the transient application of a thermal probe to the sinus venosus, end-diastolic volume is linearly related to diastolic filling time (13). Thus, mechanisms that regulate venous return to the atrium or the time available for blood to pass through the atrium into the ventricle will directly alter ventricular preload (1 6).
The reduction in passive filling noted after ANP treatment is not likely due to alterations in ventricular relaxation or the passive properties of the myocardium. ANP decreases calcium entry into myocardial cells (17), and thus, ANP might have resulted in accelerated relaxation and augmented filling. Direct calculations of the time constant of ventricular pressure decline is necessary to define altered relaxation rates. Likewise, ventricular pressure-volume relations are needed to define any effect of ANP on passive ventricular properties (12). However, as the passive properties of the embryonic myocardium are predominantly determined by cell-to-cell and extracellular matrix properties, it is unlikely that ANP has any acute effects on passive ventricular properties (18).
Our finding that active AV flow was unaffected by ANP treatment is further evidence that achieving maximal atrial volume may be less sensitive to veno/atrial coupling than is passive ventricular filling. At intrinsic heart rates, maximum atrial perimeter occurs before the completion of passive ven-
